The Government has ¢ 7,200 million destined to the purchase of vaccines against COVID-19- It is an advance to have resources available when the vaccines are ready and for sale in the international market.
This item is included in the third extraordinary budget, which is presented this Monday in the Legislative Assembly.
The resources are assigned to the Ministry of Health in order to be transferred to the National Emergency Commission (CNE), which has more expeditious mechanisms to carry out the purchase.
Those ¢ 7,200 million come from savings in interest that have been made in the management of the internal and external debt, thanks to more beneficial loans for Costa Rica that have been approved with the endorsement of the Legislative Assembly to exchange expensive debt for a cheaper one .
Thus, the resources to buy vaccines are covered with a reduction in the interest item of long-term securities, by virtue of the fact that space has been generated by the improvement of debt management, the international borrowing process and the less performance pressure on domestic securities placement.
For their part, the Ministry of Health, the Costa Rican Social Security Fund and the Ministry of Foreign Affairs and Worship analyze six vaccines, receiving technical and logistics information from each of the six laboratories: AstraZeneca, Pfizer, Sinovac, Sinofarm, Moderna and the Russian development Sputnik V.
Assessing delivery times of the product, as indicated above, in the first instance those risk groups and first responders will be vaccinated. The definition of the vulnerable population is carried out as established by the National Vaccine Commission. All products for which information has been received are for people over 18 years of age.
The country, in addition to establishing the contract with the selected pharmaceutical company or companies, will join the COVAX agreement, an international mechanism promoted by the WHO to ensure access to COVID-19 vaccines.